Movement Disord: The new crown outbreak affects the treatment of Parkinson's disease.

September 23, 2020 /--- A global survey of health professionals led by Queen Mary University of London shows that during the COVID-19 pandemic, People with Parkinson's disease in Asia, Africa and much of Latin America and South America experienced difficulties in obtaining drugs that could lead to worsening symptom control.
survey conducted by the Association for Sport Disorders in June 2020 at the peak of the COVID19 epidemic received responses from 346 members from 76 countries.
responses indicated that 88.9 per cent of low-income countries believed that access to Parkinson's drugs was affected by COVID-19, up from 22.8 per cent in high-income countries.
health professionals surveyed in low-income countries said this would lead to an increase in disability.
resource-poor countries seem to be the most affected than the richer ones.
"This study shows that patients from high-income countries in East Asia, Europe and North America are less affected, but those from low- and middle-income countries are less affected and have less access to medication, which in turn leads to a worsening of morbidity," said Dr. Alastair Noyce of the Wolfson Institute's Department of Neurology at Queen Mary University.
results provide further evidence of inequality in day-to-day care for Parkinson's disease by region and wealth, which is exacerbated by COVID-19.
.com Source: The impact of COVID-19 on access to Parkinson's diseased appeedation: Original source: Julia Ling-Yu Cheong et al, The Impact of COVID-19 on Access to Parkinson's Disease, Movement Disorders (2020). DOI: 10.1002/mds.28293 Original link: